Today: 1 May 2026
Broadcom stock drops in late trade as AI nerves bite; $4.5 billion bond sale, Wi‑Fi 8 CES push in view

Broadcom stock drops in late trade as AI nerves bite; $4.5 billion bond sale, Wi‑Fi 8 CES push in view

New York, Jan 8, 2026, 16:37 EST — After-hours

  • Broadcom (AVGO) fell about 3% in late trading, tracking a tech-led pullback
  • A term sheet showed Broadcom priced $4.5 billion of senior notes, with proceeds aimed at debt repayment and general purposes
  • Investors are eyeing Friday’s U.S. payrolls report and signs of demand for AI-linked chips and networking gear

Broadcom Inc shares fell 3.2% to $332.48 in after-hours trading on Thursday, after sliding to an intraday low of $330.52. The stock opened at $343.25 and briefly touched $343.50 before sellers pushed it lower.

The move matters because Broadcom has become a popular proxy for AI data-center spending and the plumbing around it — custom chips, networking and the software stack that runs on top. When traders cut exposure to that theme, Broadcom often lands in the first wave.

Wall Street ended mixed as technology names dipped, with the Nasdaq closing down 0.44% and the S&P 500 barely changed, while the S&P 500 tech index fell 1.5%. “While AI is still hot, there are going to be winners and losers,” said Art Hogan, chief market strategist at B. Riley Wealth, as investors looked ahead to Friday’s U.S. nonfarm payrolls report for December. Reuters

The pullback ran through chip stocks. Nvidia was down 2.1% in late trading, while the iShares Semiconductor ETF fell 1.7% and the VanEck Semiconductor ETF slipped 1.6%.

Broadcom also put fresh paper on the market this week. A free-writing prospectus filed with the SEC showed it priced $4.5 billion of senior notes — corporate bonds — across four maturities, with coupons ranging from 4.3% to 5.7% and settlement expected on Jan. 13. Broadcom said it expects net proceeds of about $4.47 billion and plans to use the money for general corporate purposes and to repay debt.

Separately, Broadcom used CES in Las Vegas to push deeper into what it calls “AI-ready” home connectivity. It announced a unified Wi‑Fi 8 platform built around its BCM4918 accelerated processing unit — a system-on-chip meant to offload networking tasks and run AI inference, or model outputs, on the device — alongside two new dual-band Wi‑Fi 8 radios. “Wi‑Fi 8 represents a turning point for the industry—where broadband, connectivity, compute, and intelligence truly converge,” said Mark Gonikberg, a senior vice president and general manager at Broadcom. Nasdaq

Early adopters may still have to wait. Tech outlets said Broadcom has started sampling the chips to early customers, with consumer products expected by the end of 2026, even as Wi‑Fi 8 puts more emphasis on reliability and lower latency than raw peak speed. The Verge noted the IEEE’s Wi‑Fi 8 standard is not expected to be finalized until 2028, meaning early hardware will lean on draft specifications.

Competition is not easing. Marvell said on Tuesday it would buy networking equipment firm XConn Technologies for $540 million as it tries to deepen its AI infrastructure lineup, after a year of pressure from larger rivals in chips and data-center networking.

But the bigger risk for Broadcom bulls has not gone away: margin math. “We expect first-quarter consolidated gross margin to be down approximately 100 basis points,” CFO Kirsten Spears said in December — about a 1 percentage point drop — as a higher mix of AI revenue weighs on profitability. Reuters

With the regular session over, traders will go into Friday watching whether the stock holds the $330 area after Thursday’s low, while macro desks focus on the Jan. 9 payrolls report. Broadcom’s next earnings are currently estimated for early March, according to MarketBeat.

Stock Market Today

  • Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK
    May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines and capital strategies amid challenging market conditions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 12:13 AM EDT Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Micron stock slides as AI-chip rally cools, even after Piper Sandler’s fresh $400 target
Previous Story

Micron stock slides as AI-chip rally cools, even after Piper Sandler’s fresh $400 target

Meta stock dips as China opens Manus AI deal review — what investors watch next
Next Story

Meta stock dips as China opens Manus AI deal review — what investors watch next

Go toTop